1 
 Quarantine Requirements for the Importation of Bovine Serum from 
the United States 
 
1. For bovine serum from the United States, only that which is manufactured by designated serum 
processing facilities is eligible to be impor ted into Taiwan. In addition, only government 
agencies, publically operated enterprises, private ente rprises, academic institutions, and 
corporations are permitted to import such products. 
 
The list of designated serum processing faciliti es named in the preceding paragraph must be 
provided by the government of the United States, after confirming their compliance with 
Articles 4(4) and 4(5), to the animal quarantine authority of Taiwan for approval and publication on its website. 
2. Bovine serum imported from the United States is prohibited from being used for the production 
of biological products for ruminants use, or for in-vivo tests/research purposes. 
3. The term "disease -free countries (zones)" used in this se t of Requirements refers to countries 
(zones) recognized by the central competent authority of Taiwan as free from foot and mouth disease and contagious bovine pleuropneumonia. 
4. To import bovine serum from the United States, the following requirements shall be complied 
with: 
1) The serum must be collected from cattle that, at the time of collection, are resident in 
disease-free countries (zones). 
2) 
If the serum is collected at slaughter, it must be collected from cattle which passed 
antemortem inspection and dressed carcasses passed post -mortem inspection by the 
competent authority of the country where the slaughterhouse is located. In addition, prior to slaughter, the cattle must not be subjected to a stunning process with a device injecting 
compressed air or gas into the crania l cavity nor to a pithing process. 
3) If the serum is not collected at slaughter, it must be collected from cattle which are found 
to be clinically healthy by physical evaluation. 
4) The serum must be manufactured in designat ed serum processing facilities which are 
located in the United States and under the supervision of the government of the United States. In addition, appropriate measures must  be taken to effectively segregate the serum 
for export to Taiwan from ineligible materia ls if these designated facilities also handle 
bovine blood materials which are not compliant with Article 4(1) to 4(3) . 
5) The serum must be filtered thro ugh a filter with mesh size 0 .22μM or less, or irradiated 
with γ-rays at a dosage of 25 kGray (2.5MR.ad) or more. In addition, it must be tested and 
found free from pathogens of mycoplasma, bovine viral diarrhea, infectious bovine rhinotracheitis and bluetongue.  
6) The serum must be produced, stored and transported in such a manner as to prevent 2 
 contamination by communicable animal dis ease pathogens transmissible through the 
product. Exporter must be advised  by the government of the United States tha t the 
consignment must meet the relevant regulations of the International Air Transport Association (IATA). 
7) The information presented on the inner package label must include product name and lot 
number.  
5. The bovine serum consignment from the United States must be accompanied by an original 
veterinary certificate issued by the animal qu arantine authority of the United States. The 
certificate must state the following information in its full detail in English: 
1) Product name, quantity, and lot number. 
2) Countries (zones) in which the cattle were r esident at the time of serum collection. 
3) Name and address of the serum processing facilities.  
4) Name and address of the exporter. 
5) Destination country, name and address of the importer. 
6) Compliance with Articles 4(1) to 4(6). 
7) Date and place the certificate was issued, name and official stamp of the issuing 
authority, and name and signature of the certifying officer.